July 14, 2015 | SOURCE: REGEN BIOPHARMA, INC.

Regen BioPharma, Inc. Presents Preclinical Proof-of- Concept of DiffronC Effectiveness at the International Society for Stem Cell Research (ISSCR) Annual Meeting